Anavex Life Sciences Corp (AVXL)

[neiu]

"At our Caulfield campus, early research results from the international
drug trial of Anavex 2-73, which aims to address the symptoms
of dementia, were positive."

"Alzheimer’s drug trial success
Early research results of Anavex 2-73, a drug which aims
to address the symptoms of dementia, are positive.
Trials at Caulfield Hospital are using Anavex, which, unlike
current medications, is the only drug designed to both relieve
symptoms and slow the disease’s progression.
The first phase of the trial began in December 2014 and the
next steps will involve further research with a larger group of
participants in 2017. "

In the Annual Report for Alfred Health posted to their website on Oct 12.
https://www.alfredhealth.org.au/contents/resources/performance/AlfredHealth-AnnualReport-2015-16.pdf

So, is someone going to tell me the healthcare organization is lying now?